Literature DB >> 1673446

Depletion of L3T4+ (CD4+) T lymphocytes prevents development of resistance to Toxoplasma gondii in mice.

F G Araujo1.   

Abstract

The role of L3T4+ (CD4+) T lymphocytes in the resistance of mice of different haplotypes to Toxoplasma gondii was examined, using the monoclonal antibody GK 1.5. Outbred Swiss-Webster or inbred CBA/Ca (H-2k), BALB/c (H-2d), and C57BL/6 (H-2b) mice injected with monoclonal antibody GK 1.5 24 h before and 24 h and 7, 15, and 21 days after oral inoculation with 10 live cysts of the low-virulence strain ME49 of T. gondii exhibited an almost complete abrogation of their antibody and cell-mediated immune responses to the parasite. Delayed-type hypersensitivity response and lymphocyte stimulation assays showed significantly reduced values compared with those of control mice inoculated with ME49 cysts but not treated with the monoclonal antibody. The number of T. gondii cysts in the brains of GK 1.5-treated mice was significantly higher than in controls. Challenge of the GK 1.5-treated and chronically infected mice with the virulent RH strain of T. gondii resulted in 100% mortality, whereas 100% of chronically infected controls survived the infection. These results suggest that L3T4+ (CD4+) T lymphocytes actively participate in the development of resistance to T. gondii and in the mechanisms controlling the formation of cysts of the parasite in the brains of mice.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1673446      PMCID: PMC257892          DOI: 10.1128/iai.59.5.1614-1619.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

Review 1.  Functional heterogeneity of CD4+ T cells in leishmaniasis.

Authors:  F Y Liew
Journal:  Immunol Today       Date:  1989-02

2.  L3T4+ T cells able to mediate parasite-specific delayed-type hypersensitivity play a role in the pathology of experimental Chagas' disease.

Authors:  M Hontebeyrie-Joskowicz; G Said; G Milon; G Marchal; H Eisen
Journal:  Eur J Immunol       Date:  1987-07       Impact factor: 5.532

3.  Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4+ T cells in mice.

Authors:  Y Suzuki; J S Remington
Journal:  J Immunol       Date:  1988-06-01       Impact factor: 5.422

4.  Differences in virulence and development of encephalitis during chronic infection vary with the strain of Toxoplasma gondii.

Authors:  Y Suzuki; F K Conley; J S Remington
Journal:  J Infect Dis       Date:  1989-04       Impact factor: 5.226

5.  In vivo immunomodulation by monoclonal anti-L3T4. 1. Effects on humoral and cell-mediated immune response.

Authors:  G E Ranges; S M Cooper; S Sriram
Journal:  Cell Immunol       Date:  1987-04-15       Impact factor: 4.868

6.  H-2 complex-linked resistance in murine toxoplasmosis.

Authors:  T C Jones; P Erb
Journal:  J Infect Dis       Date:  1985-04       Impact factor: 5.226

7.  Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo.

Authors:  S P Cobbold; A Jayasuriya; A Nash; T D Prospero; H Waldmann
Journal:  Nature       Date:  1984 Dec 6-12       Impact factor: 49.962

8.  Importance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice.

Authors:  Y Suzuki; F K Conley; J S Remington
Journal:  J Immunol       Date:  1989-09-15       Impact factor: 5.422

9.  Development of resistance to Trypanosoma cruzi in mice depends on a viable population of L3T4+ (CD4+) T lymphocytes.

Authors:  F G Araujo
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

10.  Requirement for CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice.

Authors:  A G Harmsen; M Stankiewicz
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

View more
  25 in total

1.  The Toxoplasma gondii peptide AS15 elicits CD4 T cells that can control parasite burden.

Authors:  Harshita Satija Grover; Nicolas Blanchard; Federico Gonzalez; Shiao Chan; Ellen A Robey; Nilabh Shastri
Journal:  Infect Immun       Date:  2012-07-09       Impact factor: 3.441

2.  In vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against the cyst form of Toxoplasma gondii.

Authors:  F G Araujo; J Huskinson-Mark; W E Gutteridge; J S Remington
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

3.  Organ- and disease-stage-specific regulation of Toxoplasma gondii-specific CD8-T-cell responses by CD4 T cells.

Authors:  Sonja Lütjen; Sabine Soltek; Simona Virna; Martina Deckert; Dirk Schlüter
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

4.  Toxoplasma gondii-specific immunoglobulin M limits parasite dissemination by preventing host cell invasion.

Authors:  Kevin N Couper; Craig W Roberts; Frank Brombacher; James Alexander; Lawrence L Johnson
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

5.  Resistance to Toxoplasma gondii in mice infected as neonates or exposed in utero.

Authors:  L L Johnson
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

6.  Influence of macrophage resistance gene Lsh/Ity/Bcg (candidate Nramp) on Toxoplasma gondii infection in mice.

Authors:  J M Blackwell; C W Roberts; T I Roach; J Alexander
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

7.  Anti-CD25 antibody-mediated depletion of effector T cell populations enhances susceptibility of mice to acute but not chronic Toxoplasma gondii infection.

Authors:  Kevin N Couper; Paula A Lanthier; Georgia Perona-Wright; Lawrence W Kummer; Wangxue Chen; Stephen T Smiley; Markus Mohrs; Lawrence L Johnson
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

8.  Cytokine mRNA in the central nervous system of SCID mice infected with Toxoplasma gondii: importance of T-cell-independent regulation of resistance to T. gondii.

Authors:  C A Hunter; J S Abrams; M H Beaman; J S Remington
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

9.  Effect of the strain of Toxoplasma gondii on the development of toxoplasmic encephalitis in mice treated with antibody to interferon-gamma.

Authors:  Y Suzuki; K Joh
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

10.  Feline immunodeficiency virus predisposes cats to acute generalized toxoplasmosis.

Authors:  M G Davidson; J B Rottman; R V English; M R Lappin; M B Tompkins
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.